Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients.
about
Increased unsaturation of lipids in cytoplasmic lipid droplets in DAOY cancer cells in response to cisplatin treatmentA phase I clinical trial of dose escalation of lobaplatin in combination with fixed-dose docetaxel for the treatment of human solid tumours that had progressed following chemotherapyRetrospective analysis of high intensity focused ultrasound combined with S-1 in the treatment of metastatic pancreatic cancer after failure of gemcitabineModified GTX as Second-Line Chemotherapy in Advanced Pancreatic CancerBeyond first-line chemotherapy for advanced pancreatic cancer: an expanding array of therapeutic options?Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
P2860
Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Phase II study of palliative S ...... ry pancreatic cancer patients.
@ast
Phase II study of palliative S ...... ry pancreatic cancer patients.
@en
type
label
Phase II study of palliative S ...... ry pancreatic cancer patients.
@ast
Phase II study of palliative S ...... ry pancreatic cancer patients.
@en
prefLabel
Phase II study of palliative S ...... ry pancreatic cancer patients.
@ast
Phase II study of palliative S ...... ry pancreatic cancer patients.
@en
P2093
P2860
P356
P1433
P1476
Phase II study of palliative S ...... ory pancreatic cancer patients
@en
P2093
Chan Kyu Kim
Dae Sik Hong
Han Jo Kim
Hee Sook Park
Hyun Jung Kim
Jong-Ho Won
Kyoung Ha Kim
Kyu Taek Lee
Nam Su Lee
P2860
P304
P356
10.3892/OL.2012.637
P50
P577
2012-03-08T00:00:00Z